Downregulation of miR-200a protects cardiomyocyte against apoptosis

Yansong Wang1, Yanan Jiang2, Xi Sun3

  • 1Department of Pain Management, Qunli Branch, The First Affiliated Hospital of Harbin Medical University, Harbin 150070, PR China; Department of Pharmacology (State-Province Key Laboratories of Biomedicine- Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin 150081, PR China.

Insights

MicroRNA-200a (miR-200a) is upregulated in acute myocardial infarction (AMI) and promotes apoptosis. Inhibiting miR-200a protects against AMI by downregulating Fus expression and reducing cardiomyocyte apoptosis.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • MicroRNA Research

Background:

  • Acute myocardial infarction (AMI) is a leading cause of death, with underlying molecular mechanisms requiring further elucidation.
  • Key regulators in ischemic heart disease pathogenesis, including microRNAs, remain incompletely understood.
  • This study investigates the role of miR-200a in AMI pathogenesis.

Purpose of the Study:

  • To investigate the involvement and mechanism of miR-200a in acute myocardial infarction.
  • To explore miR-200a's regulatory role in cardiomyocyte apoptosis and its potential as a therapeutic target.

Main Methods:

  • Established an AMI mouse model via left coronary artery ligation and an in vitro model using H₂O₂-treated cardiomyocytes.
  • Utilized miR-200a mimics and inhibitors (AMO-200a) for functional studies.
  • Assessed infarct size, cell apoptosis (flow cytometry), and gene/protein expression (RT-PCR, immunofluorescence, Western blot).

Main Results:

  • AMI models exhibited increased apoptosis and elevated miR-200a expression in both myocardial tissue and cardiomyocytes.
  • Inhibition of miR-200a (AMO-200a) reduced apoptosis and modulated apoptosis-related protein expression.
  • Bioinformatics and experimental data confirmed miR-200a targets Fus mRNA, with miR-200a negatively regulating Fus expression, which was downregulated in AMI models.

Conclusions:

  • The miR-200a-dependent apoptosis signaling pathway is crucial in AMI pathogenesis.
  • miR-200a and its regulation of Fus represent a potential therapeutic target for AMI.
  • Targeting miR-200a offers a promising strategy for mitigating myocardial injury in AMI.
Abstract

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.1K